Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mela Sciences Inc (MELA)

Mela Sciences Inc (MELA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mela Sciences Inc 100 LAKESIDE DRIVE SUITE 100 HORSHAM PA 19044

www.melasciences.com P: 215-619-3200

Description:

MELA Sciences, Inc., formerly known as Electro-Optical Sciences, Inc., is a medical device company focused on the design, development and commercialization of a non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma. The Company's flagship product, MelaFind, features a hand-held imaging device that emits light of multiple wavelengths to capture images of suspicious pigmented skin lesions and extract data. The data are then analyzed utilizing image processing classification algorithms, trained on its proprietary database of melanomas and benign lesions, to provide information to assist in the management of the patient, including information useful in the decision of whether to biopsy the lesion. The components of the MelaFind system include: a hand-held imaging device; a proprietary database of pigmented skin lesions; and lesion classifiers. MELA Sciences, Inc. is based in Irvington, New York.

Key Statistics

Overview:

Market Capitalization, $K 11,300
Shares Outstanding, K 9,890
Annual Sales, $ 920 K
Annual Net Income, $ -14,150 K
Last Quarter Sales, $ 8,320 K
Last Quarter Net Income, $ -9,230 K
60-Month Beta 0.19
% of Insider Shareholders 0.65%
% of Institutional Shareholders 24.22%

Growth:

1-Year Return -30.43%
3-Year Return -94.07%
5-Year Return -96.57%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -75.21%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 11/12/15
Earnings Per Share ttm -2.02
EPS Growth vs. Prev Qtr 90.00%
EPS Growth vs. Prev Year 93.18%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 07/10/14

MELA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -50.20%
Return-on-Assets % -22.12%
Profit Margin % -1,538.04%
Debt/Equity 0.00
Price/Sales 9.65
Price/Cash Flow N/A
Price/Book 0.69
Book Value/Share 1.61
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar